NM_000051.4:c.8246A>G

Variant summary

Our verdict is Uncertain significance.
+3 Uncertain · Warm
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 3 classification points (ACGS-UK Somatic Oncogenicity v2025). O3_ModerateO7_Supporting

The NM_000051.4(ATM):c.8246A>G (p.Lys2749Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The gene ATM is a tumor suppressor gene (CancerMine: 26 TSG, 31 oncogene, 24 driver citations). The gene ATM is a known oncogene (CancerMine: 26 TSG, 31 oncogene, 24 driver citations). The gene ATM is a cancer driver gene (CancerMine: 26 TSG, 31 oncogene, 24 driver citations). The variant allele was found at a cumulative frequency of 0.00000657 (AC=1) in the gnomAD database across 152,168 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.0000147. Note: a gnomAD entry for this variant shows a statistical allele-bias signature, consistent with mosaic/somatic contamination (e.g. age-related clonal hematopoiesis) rather than true inherited population frequency — this frequency should not be read as evidence of a common, benign germline variant. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 8.80). Variant has been reported in ClinVar as Uncertain Significance (★★). Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.K2749I: Uncertain_significance (ClinVar VariationId 230416, 2 stars); p.K2749= (synonymous): Benign (ClinVar VariationId 3253863, 1 star)

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000075 ( 0 hom. )

Consequence

ATM
NM_000051.4 missense

Scores

6
8
5

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: 8.80

Publications

8 publications found
Variant links:
Genes affected
ATM (HGNC:795): (ATM serine/threonine kinase) The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010]
ATM Gene-Disease associations (from GenCC):
  • ATM-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary breast carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: Natera, Ambry Genetics
  • ataxia telangiectasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Laboratory for Molecular Medicine, ClinGen, G2P, Orphanet, Natera, PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • prostate cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • gastric carcinoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • hereditary nonpolyposis colon cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
C11orf65 (HGNC:28519): (chromosome 11 open reading frame 65) Predicted to be involved in negative regulation of mitochondrial fission and obsolete negative regulation of protein targeting to mitochondrion. Predicted to be located in cytosol and mitochondrial outer membrane. [provided by Alliance of Genome Resources, Jun 2026]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000051.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 3 points.

O3Absent or very rare in population
Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = 0.000015, AC = 1 — absent/extremely rare (O3 moderate [+2])
O7Mutational hotspot or critical domain
Supporting: cancerhotspots.org hit, critical domain, or missense neighbourhood hotspot; No cancerhotspots.org hit at this position; UniProt domain: 0 pathogenic, 0 benign.; ±8 AA neighbourhood: 3 pathogenic, 2 benign (OR vs. background: 7.0); Variant does not impact splicing — splice-hotspot path not applicable

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000051.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

ATM NM_000051.4
MANE Select
HGVSc / HGVSpc.8246A>Gp.Lys2749Arg
Exon rankExon 56 of 63
missense
Prot: NP_000042.3
ATM NM_001351834.2
HGVSc / HGVSpc.8246A>Gp.Lys2749Arg
Exon rankExon 57 of 64
missense
Prot: NP_001338763.1UniProt: Q13315
C11orf65 NM_001330368.2
HGVSc / HGVSpc.641-26868T>C
Exon rankIntron 6 of 6
intron
Prot: NP_001317297.1

Ensembl Transcripts

ATM ENST00000675843.1
MANE Select
HGVSc / HGVSpc.8246A>Gp.Lys2749Arg
Exon rankExon 56 of 63
missense
Prot: ENSP00000501606.1UniProt: Q13315
ATM ENST00000452508.7
TSL:1
HGVSc / HGVSpc.8246A>Gp.Lys2749Arg
Exon rankExon 57 of 64
missense
Prot: ENSP00000388058.2UniProt: Q13315
C11orf65 ENST00000615746.4
TSL:1
HGVSc / HGVSpc.*1197-647T>C
Exon rankIntron 11 of 12
intron
Prot: ENSP00000483537.1UniProt: Q8NCR3-1

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 4 sources
GnomAD3 genomes
AF: 0.00000657
AC:1
Hom:0
AN:152168
Cov:32
GnomAD2 exomes
AF: 0.00
AC:0
AN:251016
GnomAD4 exome Warning
AF: 0.00000753
AC:11
Hom:0
AN:1459896
Cov:30
GnomAD4 genome
AF: 0.00000657
AC:1
Hom:0
AN:152168
Cov:32
Showing 4 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
Epi25
(Epilepsy)
0.0000238 141956 0.00 066880
SCHEMA
(Schizophrenia)
0.0000258 277658 0.00 0139310
Showing 2 cohortsAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
-
Hereditary cancer-predisposing syndrome (2)
-
1
-
Ataxia-telangiectasia syndrome (1)
-
1
-
not provided (1)

Computational Scores

AlphaGenome AVI
Pathogenic21
AlphaMissense
Benign0.090
BayesDel_addAF
Pathogenic0.17D
BayesDel_noAF
Uncertain0.010
CADD
Uncertain24
DANN
Pathogenic1.0
DEOGEN2
Benign0.12T
Eigen
Uncertain0.68
Eigen_PC
Pathogenic0.70
FATHMM_MKL
Pathogenic0.99D
FuncVEP CTI
Benign0.072
GPN-Star LLR
N/A-5.6
GPN-Star score
N/A5.6
LIST_S2
Uncertain0.87D
M_CAP
Uncertain0.17D
MetaRNN
Pathogenic0.78D
MetaSVM
Uncertain0.59D
Mutation Taster
N/A28/72disease causing
MutationAssessor
Benign1.3L
PhyloP100
Pathogenic8.8
PrimateAI
Uncertain0.68T
PROVEAN
Benign-2.2N
REVEL
Uncertain0.59
Sift
Pathogenic0.0D
Sift4G
Benign0.084T
Varity_R
N/A0.41
VESM-3B
Benign-4.9
Showing 27 of 27 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.